|
OMIM |
Link |
Information gain |
01 |
|
indifference to pain, congenital, autosomal dominant
|
[NCBI]
|
0.00138332
|
|
|
CMT2G
|
[NCBI]
|
0.00107278
|
|
|
RDPA
|
[NCBI]
|
0.00107278
|
|
|
neuropathy, hereditary motor and sensory, with deafness, mental retardation, and absent sensory large myelinated fibers
|
[NCBI]
|
0.00107278
|
|
|
giant axonal neuropathy, autosomal dominant
|
[NCBI]
|
0.00107278
|
|
|
carnosinemia
|
[NCBI]
|
0.000955856
|
|
|
auditory neuropathy, x-linked, 1, with peripheral sensory neuropathy
|
[NCBI]
|
0.000955856
|
|
|
auditory neuropathy, autosomal dominant, 1
|
[NCBI]
|
0.000955856
|
|
|
NGFB
|
[NCBI]
|
0.000904765
|
|
|
CMT2B2
|
[NCBI]
|
0.000880082
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
0.000880082
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000779137
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000779137
|
|
|
IOSCA
|
[NCBI]
|
0.000779137
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.000682663
|
|
|
amyotrophy, monomelic
|
[NCBI]
|
0.00065814
|
|
|
CMT1B
|
[NCBI]
|
0.000636177
|
|
|
MAG
|
[NCBI]
|
0.000607657
|
|
|
PMP22
|
[NCBI]
|
0.000400176
|
|
|
HNPP
|
[NCBI]
|
0.000379094
|
|
|
ALD
|
[NCBI]
|
0.0003606
|
|
|
HSAN2
|
[NCBI]
|
0.00030515
|
|
|
RA
|
[NCBI]
|
0.000278213
|
|
|
neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive
|
[NCBI]
|
0.000276189
|
|
|
krabbe disease
|
[NCBI]
|
0.000262985
|
|
|
ALS4
|
[NCBI]
|
0.000222336
|
|
|
MJD
|
[NCBI]
|
0.000214198
|
|
|
CNTF
|
[NCBI]
|
0.000207344
|
|
|
CMT4B1
|
[NCBI]
|
0.000203247
|
|
|
CMT4C
|
[NCBI]
|
0.000203247
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
0.000196755
|
|
|
CMT2A2
|
[NCBI]
|
0.000195718
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
0.000177946
|
|
|
CLN2
|
[NCBI]
|
0.000172992
|
|
|
VED
|
[NCBI]
|
0.00016853
|
|
|
TTR
|
[NCBI]
|
0.000168214
|
|
|
CMT4J
|
[NCBI]
|
0.00016501
|
|
|
hypertrophic neuropathy and cataract
|
[NCBI]
|
0.00016501
|
|
|
charcot-marie-tooth disease with ptosis and parkinsonism
|
[NCBI]
|
0.00016501
|
|
|
cerebral sclerosis similar to pelizaeus-merzbacher disease
|
[NCBI]
|
0.00016501
|
|
|
peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and spongy degeneration of brain
|
[NCBI]
|
0.00016501
|
|
|
insensitivity to pain with hyperplastic myelinopathy
|
[NCBI]
|
0.00016501
|
|
|
BDNF
|
[NCBI]
|
0.000164785
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
0.000164406
|
|
|
SPG3A
|
[NCBI]
|
0.000153638
|
|
|
TGD
|
[NCBI]
|
0.000147495
|
|
|
PNPLA6
|
[NCBI]
|
0.000135294
|
|
|
PFIC1
|
[NCBI]
|
0.000134662
|
|
|
SLE
|
[NCBI]
|
0.000133951
|
|
|
GDNF
|
[NCBI]
|
0.000128913
|
|
|
spinal muscular atrophy, scapuloperoneal
|
[NCBI]
|
0.000125816
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
0.000125816
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
0.000125816
|
|
|
GBS
|
[NCBI]
|
0.000125816
|
|
|
NEM3
|
[NCBI]
|
0.000124349
|
|
|
ATF3
|
[NCBI]
|
0.000123367
|
|
|
OPMD
|
[NCBI]
|
0.000121069
|
|
|
GJB1
|
[NCBI]
|
0.000120937
|
|
|
MPZ
|
[NCBI]
|
0.000119065
|
|
|
MBP
|
[NCBI]
|
0.000116186
|
|
|
SMAX1
|
[NCBI]
|
0.000115868
|
|
|
muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers
|
[NCBI]
|
0.000111075
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
0.000111075
|
|
|
EGF
|
[NCBI]
|
0.000106949
|
|
|
adie pupil
|
[NCBI]
|
0.000101531
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
0.000101531
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
0.000101531
|
|
|
CMT4H
|
[NCBI]
|
0.000101531
|
|
|
MUC1
|
[NCBI]
|
0.000100214
|
|
|
valproate embryopathy, susceptibility to
|
[NCBI]
|
9.4456e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
9.02336e-05
|
|
|
CMT1A
|
[NCBI]
|
8.65875e-05
|
|
|
DFNB9
|
[NCBI]
|
8.41741e-05
|
|
|
CMT4B2
|
[NCBI]
|
8.41741e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
8.41741e-05
|
|
|
FRDA
|
[NCBI]
|
8.15978e-05
|
|
|
SPG17
|
[NCBI]
|
8.01963e-05
|
|
|
SCAR1
|
[NCBI]
|
7.6729e-05
|
|
|
SACS
|
[NCBI]
|
7.6729e-05
|
|
|
CMT4D
|
[NCBI]
|
7.6729e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
7.3658e-05
|
|
|
NPY
|
[NCBI]
|
7.27532e-05
|
|
|
TNF
|
[NCBI]
|
7.20939e-05
|
|
|
canavan disease
|
[NCBI]
|
7.09036e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
7.09036e-05
|
|
|
EA1
|
[NCBI]
|
7.09036e-05
|
|
|
mannosidosis, beta a, lysosomal
|
[NCBI]
|
6.8408e-05
|
|
|
HMN5
|
[NCBI]
|
6.8408e-05
|
|
|
CMT2A1
|
[NCBI]
|
6.8408e-05
|
|
|
CMT4A
|
[NCBI]
|
6.8408e-05
|
|
|
CIPA
|
[NCBI]
|
6.61278e-05
|
|
|
ACCPN
|
[NCBI]
|
6.40298e-05
|
|
|
INAD1
|
[NCBI]
|
6.2088e-05
|
|
|
EAOH
|
[NCBI]
|
6.2088e-05
|
|
|
CDS
|
[NCBI]
|
6.02813e-05
|
|
|
danon disease
|
[NCBI]
|
5.8593e-05
|
|
|
MDC1A
|
[NCBI]
|
5.41095e-05
|
|
|
MSS
|
[NCBI]
|
5.27759e-05
|
|
|
VEGF
|
[NCBI]
|
5.15847e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
5.03052e-05
|
|
|
LGMD2C
|
[NCBI]
|
4.91566e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
4.91566e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
4.91566e-05
|
|
|
AKR1B1
|
[NCBI]
|
4.70685e-05
|
|
|
SCA6
|
[NCBI]
|
4.70094e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
4.6683e-05
|
|
|
MTMR2
|
[NCBI]
|
4.61866e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
4.6003e-05
|
|
|
ACHE
|
[NCBI]
|
4.48247e-05
|
|
|
HSAN3
|
[NCBI]
|
4.41086e-05
|
|
|
CHAC
|
[NCBI]
|
4.41086e-05
|
|
|
LAMC3
|
[NCBI]
|
4.36599e-05
|
|
|
XPA
|
[NCBI]
|
4.32151e-05
|
|
|
NGFR
|
[NCBI]
|
4.24594e-05
|
|
|
EGR2
|
[NCBI]
|
4.23837e-05
|
|
|
PRX
|
[NCBI]
|
4.23837e-05
|
|
|
CMTX1
|
[NCBI]
|
4.23541e-05
|
|
|
CSA
|
[NCBI]
|
3.91969e-05
|
|
|
GALC
|
[NCBI]
|
3.87505e-05
|
|
|
MFN2
|
[NCBI]
|
3.81265e-05
|
|
|
SCA2
|
[NCBI]
|
3.77674e-05
|
|
|
DHH
|
[NCBI]
|
3.75299e-05
|
|
|
SCA7
|
[NCBI]
|
3.70853e-05
|
|
|
ABL
|
[NCBI]
|
3.70853e-05
|
|
|
AMC
|
[NCBI]
|
3.51556e-05
|
|
|
kiaa0274
|
[NCBI]
|
3.3693e-05
|
|
|
ARHGEF10
|
[NCBI]
|
3.3693e-05
|
|
|
CJD
|
[NCBI]
|
3.19029e-05
|
|
|
HOS
|
[NCBI]
|
3.07173e-05
|
|
|
HSN2
|
[NCBI]
|
2.99415e-05
|
|
|
TDP1
|
[NCBI]
|
2.99415e-05
|
|
|
LASS1
|
[NCBI]
|
2.99415e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
2.97397e-05
|
|
|
PSAP
|
[NCBI]
|
2.91313e-05
|
|
|
MTM1
|
[NCBI]
|
2.83557e-05
|
|
|
PTH
|
[NCBI]
|
2.82514e-05
|
|
|
MG
|
[NCBI]
|
2.80726e-05
|
|
|
ADAM22
|
[NCBI]
|
2.75112e-05
|
|
|
MOX2
|
[NCBI]
|
2.75112e-05
|
|
|
TBX18
|
[NCBI]
|
2.75112e-05
|
|
|
ISL2
|
[NCBI]
|
2.75112e-05
|
|
|
JAM3
|
[NCBI]
|
2.57083e-05
|
|
|
DRP2
|
[NCBI]
|
2.57083e-05
|
|
|
AGR2
|
[NCBI]
|
2.57083e-05
|
|
|
NPC1
|
[NCBI]
|
2.50767e-05
|
|
|
SCA1
|
[NCBI]
|
2.50767e-05
|
|
|
GDF1
|
[NCBI]
|
2.42749e-05
|
|
|
NF1
|
[NCBI]
|
2.41005e-05
|
|
|
NEUROG3
|
[NCBI]
|
2.30858e-05
|
|
|
FGD4
|
[NCBI]
|
2.30858e-05
|
|
|
POU3F1
|
[NCBI]
|
2.20702e-05
|
|
|
SACS
|
[NCBI]
|
2.20702e-05
|
|
|
NRP2
|
[NCBI]
|
2.11844e-05
|
|
|
SPG3A
|
[NCBI]
|
2.11844e-05
|
|
|
SLC18A1
|
[NCBI]
|
2.11844e-05
|
|
|
NEUROG2
|
[NCBI]
|
2.11844e-05
|
|
|
AVP
|
[NCBI]
|
1.97794e-05
|
|
|
NDRG1
|
[NCBI]
|
1.96948e-05
|
|
|
IL23A
|
[NCBI]
|
1.96948e-05
|
|
|
GARS
|
[NCBI]
|
1.96948e-05
|
|
|
fabry disease
|
[NCBI]
|
1.93097e-05
|
|
|
PRPH
|
[NCBI]
|
1.90559e-05
|
|
|
OTOF
|
[NCBI]
|
1.90559e-05
|
|
|
GDAP1
|
[NCBI]
|
1.84719e-05
|
|
|
CRH
|
[NCBI]
|
1.82416e-05
|
|
|
NEFL
|
[NCBI]
|
1.79341e-05
|
|
|
NTF3
|
[NCBI]
|
1.79341e-05
|
|
|
SPG7
|
[NCBI]
|
1.69724e-05
|
|
|
AR
|
[NCBI]
|
1.67058e-05
|
|
|
ANGPTL4
|
[NCBI]
|
1.65387e-05
|
|
|
HPX
|
[NCBI]
|
1.57481e-05
|
|
|
CALCA
|
[NCBI]
|
1.50422e-05
|
|
|
PMD
|
[NCBI]
|
1.50343e-05
|
|
|
CPM
|
[NCBI]
|
1.41088e-05
|
|
|
SMS
|
[NCBI]
|
1.38448e-05
|
|
|
HSPB1
|
[NCBI]
|
1.38254e-05
|
|
|
CRYAB
|
[NCBI]
|
1.38254e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.38039e-05
|
|
|
PCNA
|
[NCBI]
|
1.37492e-05
|
|
|
CD59
|
[NCBI]
|
1.3554e-05
|
|
|
TSD
|
[NCBI]
|
1.347e-05
|
|
|
DFSP
|
[NCBI]
|
1.32865e-05
|
|
|
DAG1
|
[NCBI]
|
1.30437e-05
|
|
|
ARSA
|
[NCBI]
|
1.15278e-05
|
|
|
MAPK14
|
[NCBI]
|
1.08049e-05
|
|
|
EPO
|
[NCBI]
|
1.01977e-05
|
|
|
GFAP
|
[NCBI]
|
1.01343e-05
|
|
|
GAPDH
|
[NCBI]
|
9.90388e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
9.86245e-06
|
|
|
VIP
|
[NCBI]
|
9.58847e-06
|
|
|
DMD
|
[NCBI]
|
9.40672e-06
|
|
|
CHAT
|
[NCBI]
|
9.18455e-06
|
|
|
HEXA
|
[NCBI]
|
8.92773e-06
|
|
|
GAL
|
[NCBI]
|
8.86974e-06
|
|
|
ABCD1
|
[NCBI]
|
7.91877e-06
|
|
|
TLR3
|
[NCBI]
|
7.52481e-06
|
|
|
AFP
|
[NCBI]
|
7.3816e-06
|
|
|
LMNA
|
[NCBI]
|
7.071e-06
|
|
|
PYY
|
[NCBI]
|
6.77459e-06
|
|
|
HMBS
|
[NCBI]
|
5.71435e-06
|
|
|
CHS
|
[NCBI]
|
5.07491e-06
|
|
|
VIM
|
[NCBI]
|
4.77342e-06
|
|
|
PTN
|
[NCBI]
|
4.51756e-06
|
|
|
CALCRL
|
[NCBI]
|
4.37148e-06
|
|
|
PRNP
|
[NCBI]
|
4.27701e-06
|
|
|
TNC
|
[NCBI]
|
3.6743e-06
|
|
|
AGER
|
[NCBI]
|
3.51896e-06
|
|
|
PI
|
[NCBI]
|
3.48119e-06
|
|
|
DMD
|
[NCBI]
|
3.33413e-06
|
|
|
TH
|
[NCBI]
|
3.3228e-06
|
|
|
OMP
|
[NCBI]
|
3.12503e-06
|
|
|
KLK3
|
[NCBI]
|
2.97557e-06
|
|
|
MCP
|
[NCBI]
|
2.89717e-06
|
|
|
RB1
|
[NCBI]
|
2.5705e-06
|
|
|
FAAH
|
[NCBI]
|
2.54255e-06
|
|
|
temporal arteritis
|
[NCBI]
|
2.31709e-06
|
|
|
SPP1
|
[NCBI]
|
2.25626e-06
|
|
|
RNASE3
|
[NCBI]
|
1.86069e-06
|
|
|
AT
|
[NCBI]
|
1.73293e-06
|
|
|
SLC18A3
|
[NCBI]
|
1.71743e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.41959e-06
|
|
|
CDK5
|
[NCBI]
|
7.83541e-07
|
|
|
RASA1
|
[NCBI]
|
7.40132e-07
|
|
|
XDH
|
[NCBI]
|
6.04731e-07
|
|
|
ALB
|
[NCBI]
|
5.55971e-07
|
|
|
CCK
|
[NCBI]
|
5.52658e-07
|
|
|
SDC2
|
[NCBI]
|
4.72539e-07
|
|
|
TF
|
[NCBI]
|
3.73803e-07
|
|
|
NPPA
|
[NCBI]
|
2.56573e-07
|
|
|
GHRH
|
[NCBI]
|
2.23376e-07
|
|
|
STAT3
|
[NCBI]
|
1.99241e-07
|
|
|
APOE
|
[NCBI]
|
5.20335e-08
|
|
|
CD
|
[NCBI]
|
4.27945e-08
|
|
|
SHH
|
[NCBI]
|
1.93337e-08
|
|